Fe 992097 (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 193 | Prader-Willi syndrome | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01968187 (ClinicalTrials.gov) | January 2014 | 9/10/2013 | Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome | Hyperphagia in Prader-Willi Syndrome | Drug: FE 992097;Drug: Placebo | Ferring Pharmaceuticals | NULL | Completed | 10 Years | 18 Years | Both | 38 | Phase 2 | United States |